INS and type 2 diabetes mellitus: The use of antihyperglycaemic therapy (non-insulin drugs and/or insulin) decreased moderately in both SC and TC patients with T2DM (SC: 80.1 to 76.3%, p = 0.019; TC: 78.2 to 70.2%, p < 0.001).